Adaptation and Testing of a Novel Text-based Tobacco Cessation and Education Intervention in Kenyan Emergency Department Patients

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorYale University

About this trial

In this study, investigators will adapt and implement Text2Quit in a Kenyan ED population will increase knowledge and cessation. Investigators will use a mixed-methods, hybrid implementation-effectiveness approach to assess these outcomes. Results will inform a randomized, controlled trial in a nationally representative sample of EDs in future. This study will be the first to target tobacco use in this population, the first to use mobile cessation, and will contribute to advancing implementation science on tobacco cessation globally. It will also provide a novel approach to implementation for mHealth interventions, with findings that can be generalized to other Non-Communicable Diseases and risk factors, such as alcohol use, hypertension and diabetes.

Eligibility criteria

Qualifiers

Current tobacco users (self-identified smokers).

Presenting to the Emergency Department (ED) at Kenyatta National Hospital (KNH).

Own a mobile phone capable of receiving text messages.

Willing to quit tobacco use.

Disqualifiers

Individuals unwilling or unable to provide consent.

Non-tobacco users.

Those without access to a mobile phone.

Patients who are critically ill or otherwise unable to participate (practically excluded at triage).

Trial design

Treatments tested in this trial

  • Text2Quit-Kenya

Treatment groups

285 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Yale University

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator